Slides (PDF)
Keep Calm and Carry OnPractical prescribing in kidney disease · cheat sheet · Douneside House, 20 November 2026 · Dr Shona Methven, NHS Grampian

The pillars

DrugStart whenCheckKeep calm whenPause or stop when
ACEi / ARBCKD with diabetes and ACR over 3; CKD with hypertension and ACR over 30; any CKD with ACR 70 or more. Titrate to max toleratedU&E and K before, then 1 to 2 weeks after start and each dose riseeGFR down less than 25% (or creatinine up less than 30%): no change, recheck in 1 to 2 weeks; K 5.1 to 5.9 (repeat it first). No eGFR cut-off for stopping (STOP-ACEi)eGFR down 25% or more (or creatinine up 30% or more): look for NSAIDs, volume depletion first; reduce or stop only if no other cause and it persists. K 6.0 or more; sick days
SGLT2iT2DM: first line with metformin MR (NICE NG28 2026). Start alongside the ACEi/ARB, within weeks. CKD on ACEi/ARB: dapagliflozin or empagliflozin at eGFR 20 to under 45, or 45 to 90 with T2DM or uACR 22.6 or more (NICE TA1075, TA942; SMC)No routine early bloods needed (UKKA). Assess DKA risk.Early eGFR dip: expected and protectiveSick days, fasting, surgery, acute serious illness in hospital. Active foot disease. Stop at dialysis.
FinerenoneT2DM, CKD 3 to 4, ACR 3 or more, eGFR 25 or more, on highest tolerated ACEi/ARB plus SGLT2i (NICE TA877). SMC2486: acceptedK and eGFR at 4 weeks: if K under 5.0, increase to 20 mg; then regularly. Start 10 mg (eGFR 25 to 59) if K under 5.0; don't start at 5.0 or above (NHS Grampian)K up to 5.5: continue with monitoring (SmPC)K over 5.5: withhold, restart 10 mg when K 5.0 or less; sick days (agree locally); stop at end-stage kidney disease
GLP-1 RANICE NG28 2026: subcutaneous semaglutide up to 1 mg first line with ASCVD; consider as add-on in obesity and early-onset T2DM. Not recommended on the CKD track aloneGI tolerance; semaglutide needs no renal dose changeNausea settles with slow titrationVomiting and dehydration (AKI risk); pancreatitis; visual loss (NAION)
MetforminFirst line (MR)eGFReGFR 30 to 45: max 1 g a dayeGFR under 30; sick days
StatinCKD primary prevention: atorvastatin 20 mg. Secondary: high intensity, aim LDL 2.0 or less (non-HDL 2.6); add ezetimibe (NICE NG238)Lipids, LFTsStarting dialysis: continueDon't start one in someone already on dialysis (KDIGO)

Sick days (Scotland, v4 2026)

  • When: 2 or more episodes of vomiting or diarrhoea, or fever, sweats, shaking (unless mild)
  • Pause: SGLT2i, ACEi, ARB, diuretics, metformin, NSAIDs (+ others agreed locally)
  • Restart: after 24 to 48 h of eating and drinking normally
  • Write the restart plan down (card, repeat note, discharge letter, KIS). Pause is not stop.

Potassium

  • Over 5.0: don't start ACEi/ARB until causes are addressed
  • 5.1 to 5.9: continue; review NSAIDs, trimethoprim, K-sparing diuretics, salt substitutes, acidosis
  • 6.0 or more: stop ACEi/ARB after stopping other culprits
  • Persistent 5.5 or more (CKD 3b to 5 or heart failure): Lokelma to keep RAAS blockade (SMC2884, NICE TA1148)
  • Finerenone: withhold above 5.5

DOACs: calculate, don't read off eGFR

  • Use Cockcroft-Gault CrCl with a current weight, not the one on the record (MHRA 2019)
  • Apixaban 2.5 mg bd: CrCl 15 to 29, or 2 of: age 80+, weight 60 kg or less, creatinine 133+
  • Edoxaban 30 mg: CrCl 15 to 50 · Rivaroxaban 15 mg: CrCl 15 to 49
  • Dabigatran: contraindicated below CrCl 30
  • Over 12 months after ACS with AF: DOAC alone, stop the antiplatelet (check complex stents with cardiology)

On dialysis

  • Stop: SGLT2i (continue until dialysis starts), finerenone (stop at end-stage kidney disease), metformin (already stopped below eGFR 30)
  • Review: ACEi/ARB (BP, heart, residual function, K); GLP-1 RA and apixaban (limited data, off-label on dialysis): renal team
  • Continue: statin already started; beta-blocker for a cardiac indication
  • Refer earlier: 5-year KFRE over 5% or ACR 70+ (NICE NG203); kidneyfailurerisk.co.uk
Keep calm and
Start both
Keep calm and
Accept the dip
Keep calm and
Recheck the potassium
Keep calm and
Stack the pillars
Keep calm and
Restart
Keep calm and
Calculate
Keep calm and
Keep the statin
Keep calm and
Carry on
Slides as a PDF handout: douneside.jamiersmith.com/slides.pdf. Teaching summary prepared November 2026, not a substitute for the BNF, SmPCs, NICE/SMC advice or local NHS Board guidance. Sources: NICE NG203 (CKD), NG28 (type 2 diabetes, Feb 2026 update), NG238 (lipids), TA1075, TA942, TA877, TA1148 (Apr 2026); SMC2486, SMC2642, SMC2763, SMC2884 (Aug 2026); UK Kidney Association SGLT-2i guideline 2023; Scottish Government / Healthcare Improvement Scotland Medication Sick Day Guidance v4 (2026); STOP-ACEi (NEJM 2022); MHRA Drug Safety Update Oct 2019; AFIRE (NEJM 2019); EPIC-CAD (NEJM 2024); KDIGO Lipid Guideline 2013; FLOW (NEJM 2024). Reviewed 12 Nov 2026.